CCXI logo

ChemoCentryx (CCXI) Operating Profit

Annual Operating Profit

-$129.92 M
-$74.74 M-135.46%

December 31, 2021


Summary


Performance

CCXI Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherCCXIprofitabilitymetrics:

Quarterly Operating Profit

-$31.57 M
+$6.66 M+17.42%

June 30, 2022


Summary


Performance

CCXI Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherCCXIprofitabilitymetrics:

TTM Operating Profit

-$131.66 M
+$7.16 M+5.16%

June 30, 2022


Summary


Performance

CCXI TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherCCXIprofitabilitymetrics:

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

CCXI Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-135.5%+18.5%-8.4%
3 y3 years-222.6%-97.1%-125.8%
5 y5 years-887.7%-229.7%-125.8%

CCXI Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat lowat high+26.8%+1.3%+5.4%
5 y5-year+135.5%at low-254.9%+26.8%+318.1%+5.4%
alltimeall time-887.7%at low-180.4%+26.8%-898.3%+5.4%

ChemoCentryx Operating Profit History

DateAnnualQuarterlyTTM
Jun 2022
-
-$31.57 M(-17.4%)
-$131.66 M(-5.2%)
Mar 2022
-
-$38.23 M(-4.5%)
-$138.82 M(+6.9%)
Dec 2021
-$129.92 M(+135.5%)
-$40.05 M(+83.7%)
-$129.92 M(+8.8%)
Sep 2021
-
-$21.80 M(-43.7%)
-$119.45 M(-1.7%)
Jun 2021
-
-$38.74 M(+32.1%)
-$121.50 M(+94.8%)
Mar 2021
-
-$29.33 M(-0.9%)
-$62.38 M(+13.1%)
Dec 2020
-$55.18 M(-5.4%)
-$29.58 M(+24.0%)
-$55.18 M(+32.3%)
Sep 2020
-
-$23.86 M(-217.0%)
-$41.72 M(+32.5%)
Jun 2020
-
$20.39 M(-192.1%)
-$31.49 M(-53.6%)
Mar 2020
-
-$22.12 M(+37.2%)
-$67.90 M(+16.5%)
Dec 2019
-$58.30 M(+44.8%)
-$16.12 M(+18.3%)
-$58.30 M(+8.8%)
Sep 2019
-
-$13.63 M(-14.9%)
-$53.58 M(+4.1%)
Jun 2019
-
-$16.02 M(+27.9%)
-$51.48 M(+19.9%)
Mar 2019
-
-$12.53 M(+9.9%)
-$42.94 M(+6.6%)
Dec 2018
-$40.27 M(-344.2%)
-$11.40 M(-1.2%)
-$40.27 M(-486.5%)
Sep 2018
-
-$11.53 M(+54.1%)
$10.42 M(-30.7%)
Jun 2018
-
-$7.49 M(-24.1%)
$15.04 M(+16.1%)
Mar 2018
-
-$9.86 M(-125.1%)
$12.95 M(-21.5%)
Dec 2017
$16.49 M(-140.5%)
$39.29 M(-668.6%)
$16.49 M(-153.7%)
Sep 2017
-
-$6.91 M(-27.8%)
-$30.71 M(-1.4%)
Jun 2017
-
-$9.58 M(+51.7%)
-$31.14 M(-1.8%)
Mar 2017
-
-$6.31 M(-20.3%)
-$31.70 M(-22.1%)
Dec 2016
-$40.72 M
-$7.92 M(+8.0%)
-$40.72 M(-8.4%)
Sep 2016
-
-$7.33 M(-27.7%)
-$44.46 M(-9.0%)
Jun 2016
-
-$10.14 M(-33.8%)
-$48.88 M(-4.0%)
DateAnnualQuarterlyTTM
Mar 2016
-
-$15.33 M(+31.5%)
-$50.91 M(+6.8%)
Dec 2015
-$47.69 M(+0.6%)
-$11.66 M(-0.7%)
-$47.69 M(-1.3%)
Sep 2015
-
-$11.74 M(-3.6%)
-$48.32 M(+1.4%)
Jun 2015
-
-$12.18 M(+0.6%)
-$47.63 M(-0.4%)
Mar 2015
-
-$12.11 M(-1.5%)
-$47.84 M(+0.9%)
Dec 2014
-$47.40 M(+21.2%)
-$12.29 M(+11.2%)
-$47.40 M(+5.8%)
Sep 2014
-
-$11.05 M(-10.7%)
-$44.78 M(+3.5%)
Jun 2014
-
-$12.38 M(+6.1%)
-$43.28 M(+6.9%)
Mar 2014
-
-$11.67 M(+20.7%)
-$40.49 M(+3.5%)
Dec 2013
-$39.12 M(-1.3%)
-$9.67 M(+1.2%)
-$39.12 M(-0.6%)
Sep 2013
-
-$9.55 M(-0.5%)
-$39.34 M(-1.7%)
Jun 2013
-
-$9.60 M(-6.7%)
-$40.03 M(-3.5%)
Mar 2013
-
-$10.29 M(+3.9%)
-$41.47 M(+4.6%)
Dec 2012
-$39.63 M(+821.4%)
-$9.90 M(-3.3%)
-$39.63 M(+259.7%)
Sep 2012
-
-$10.24 M(-7.3%)
-$11.02 M(+16.8%)
Jun 2012
-
-$11.04 M(+30.6%)
-$9.43 M(+48.0%)
Mar 2012
-
-$8.45 M(-145.2%)
-$6.37 M(+48.2%)
Dec 2011
-$4.30 M(-27.8%)
$18.71 M(-316.3%)
-$4.30 M(-78.5%)
Sep 2011
-
-$8.65 M(+8.4%)
-$19.97 M(-1.1%)
Jun 2011
-
-$7.98 M(+25.1%)
-$20.19 M(+65.4%)
Mar 2011
-
-$6.38 M(-309.6%)
-$12.21 M(+109.4%)
Dec 2010
-$5.96 M(-138.0%)
$3.04 M(-134.3%)
-$5.83 M(-34.3%)
Sep 2010
-
-$8.88 M
-$8.88 M
Dec 2009
$15.70 M(-178.0%)
-
-
Dec 2008
-$20.13 M
-
-

FAQ

  • What is ChemoCentryx annual operating income?
  • What is the all time high annual operating profit for ChemoCentryx?
  • What is ChemoCentryx annual operating profit year-on-year change?
  • What is ChemoCentryx quarterly operating income?
  • What is the all time high quarterly operating profit for ChemoCentryx?
  • What is ChemoCentryx quarterly operating profit year-on-year change?
  • What is ChemoCentryx TTM operating income?
  • What is the all time high TTM operating profit for ChemoCentryx?
  • What is ChemoCentryx TTM operating profit year-on-year change?

What is ChemoCentryx annual operating income?

The current annual operating profit of CCXI is -$129.92 M

What is the all time high annual operating profit for ChemoCentryx?

ChemoCentryx all-time high annual operating income is $16.49 M

What is ChemoCentryx annual operating profit year-on-year change?

Over the past year, CCXI annual operating income has changed by -$74.74 M (-135.46%)

What is ChemoCentryx quarterly operating income?

The current quarterly operating profit of CCXI is -$31.57 M

What is the all time high quarterly operating profit for ChemoCentryx?

ChemoCentryx all-time high quarterly operating income is $39.29 M

What is ChemoCentryx quarterly operating profit year-on-year change?

Over the past year, CCXI quarterly operating income has changed by +$7.16 M (+18.49%)

What is ChemoCentryx TTM operating income?

The current TTM operating profit of CCXI is -$131.66 M

What is the all time high TTM operating profit for ChemoCentryx?

ChemoCentryx all-time high TTM operating income is $16.49 M

What is ChemoCentryx TTM operating profit year-on-year change?

Over the past year, CCXI TTM operating income has changed by -$10.16 M (-8.36%)